Skip to main content
Caplight Logo









SyMap Medical

SyMap Medical

Private
SuzhouHealthcare & Life Scienceshttps://www.symapmedical.com/

Last Round

Series E

Dec 1, 2021

Total Funding Raised

$135.5M

Company Overview

SyMap Medical is a medical device company that develops and manufactures minimally invasive interventional devices for the treatment of cardiovascular and respiratory diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

renal denervationRDNradiofrequency ablationhypertension treatmentinterventional cardiologynerve mappingmedical devicebronchial ablationdrug-resistant hypertensioncatheter-based therapyblood pressure managementminimally invasive surgeryinterventional medicinemedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SyMap Medical Comparables

Compare SyMap Medical with similar companies based on industry and business-model similarity.

SyMap Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Shanghai Golden Leaf Med Tech Co., Ltd.
88%
Cortex, Inc.
81%
Pulnovo Medical
79%

SyMap Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series EDec 1, 2021
Series DDec 22, 2020
Series CNov 1, 2018
Series BAug 22, 2015

SyMap Medical Investors

Notable investors and investment history

SyMap Medical investors
InvestorRounds
VMS Asset ManagementSeries E
Puhua CapitalSeries D
HongShan Capital Group (HSG)Series E, Series B
SB China CapitalSeries B
Primavera Capital GroupSeries E

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 17, 2024

    Monthly visitors increased 511% MoM.

  • Aug 22, 2015

    $10M round led by HongShan

SyMap Medical Filings

Explore SEC and related filing metadata, where available.

SyMap Medical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about SyMap Medical's valuation, stock price, and market status.

Is SyMap Medical a public or private company?

SyMap Medical is a private company.

What is the current stock price of SyMap Medical?

SyMap Medical is a private company with no public stock price. No recent secondary market data is available.

How much is SyMap Medical worth (valuation)?

Valuation information for SyMap Medical is not publicly available.

Can I buy SyMap Medical stock?

SyMap Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was SyMap Medical's last funding round?

SyMap Medical's most recent funding round was Series E on December 1, 2021.

Who are the main investors in SyMap Medical?

Key investors in SyMap Medical include VMS Asset Management, HongShan, Primavera Capital Group.

Will SyMap Medical IPO soon?

No public IPO plans have been announced for SyMap Medical.

How can I track SyMap Medical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SyMap Medical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSuzhou
Employee Range1
Year Founded2012
Last FundingDec 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?